Intended for healthcare professionals

General Practice

Prospective case-control study of role of infection in patients who reconsult after initial antibiotic treatment for lower respiratory tract infection in primary care

BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7117.1206 (Published 08 November 1997) Cite this as: BMJ 1997;315:1206
  1. John Macfarlane, consultant physiciana,
  2. Janet Prewett, research administratora,
  3. Donald Rose, consultant radiologista,
  4. Philip Gard, principal in general practiceb,
  5. Richard Cunningham, senior registrar in microbiologyc,
  6. Pekka Saikku, research professord,
  7. Stephanie Euden, research techniciane,
  8. Steven Myint, professor of clinical microbiologye
  1. a Respiratory Infection Unit, Nottingham City Hospital, Nottingham NG5 1PB
  2. b Arnold Health Centre, Nottingham NG5 7BQ
  3. c Department of Microbiology and Public Health Laboratory Service, University Hospital, Nottingham NG7 2UH
  4. d Chlamydia Laboratory, National Public Health Institute Department in Oulu, 90101 Oulu, Finland
  5. e Department of Microbiology and Immunology, University of Leicester, Leicester LE1 9HN
  1. Correspondence to: Dr Macfarlane
  • Accepted 1 August 1997

Abstract

Objective: To assess direct and indirect evidence of active infection which may benefit from further antibiotics in adults who reconsult within 4 weeks of initial antibiotic management of acute lower respiratory tract infection in primary care.

Design: Observational study with a nested case-control group.

Setting: Two suburban general practices in Arnold, Nottingham, over 7 winter months.

Subjects: 367 adults aged 16 years and over fulfilling a definition of lower respiratory tract infection and treated with antibiotics. 74 (20%) patients who reconsulted within 4 weeks for the same symptoms and 82 “control” patients who did not were investigated in detail at follow up.

Main outcome measures: Direct and indirect evidence of active infection at the time of the reconsultation or the follow up visit with the research nurse for the controls. Investigations performed included sputum culture, pneumococcal antigen detection, serial serology for viral and atypical pathogens and C reactive protein, throat swabs for detecting viral and atypical pathogens by culture and polymerase chain reaction, and chest radiographs.

Results: Demographic and clinical features of the groups were similar. Two thirds of the 74 patients who reconsulted received another antibiotic because the general practitioner suspected continuing infection. Any evidence of infection warranting antibiotic treatment was uncommon at reconsultation. The findings for the two groups were similar for the occurrence of identified pathogens; chest x ray changes of infection (present in 13%); and C reactive protein concentrations, which had nearly all fallen towards normal. Only three patients in the reconsultation group had concentrations ≥40 mg/l. Pathogens identified at follow up in the 156 patients in both groups included ampicillin sensitive bacteria in six. Atypical infections diagnosed in 27 (Chlamydia pneumoniae in 22) and viral infections in 54 had probably been present at the initial presentation.

Conclusion: Our study suggests that active infection, which may benefit from further antibiotics, is uncommon in patients who reconsult after a lower respiratory tract infection, and a repeat antibiotic prescription should be the exception rather than the rule. Other factors, such as patients' perception of their illness, may be more important than disease and infection in their decision to reconsult.

Key messages

  • Lower respiratory tract infections are very common, but even if they have been given antibiotics, a fifth to a quarter of patients reconsult and many receive further antibiotics

  • No demographic or clinical features at presentation identify those who may reconsult

  • Direct and indirect evidence of infection warranting antibiotics is uncommon in those who reconsult and no different to those who do not

  • Chlamydia pneumoniae is the commonest infection identified in this study population

  • Antibiotics should be the exception rather than the rule for patients who reconsult

Footnotes

  • Accepted 1 August 1997
View Full Text